These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 14131781

  • 1. FURTHER EXPERIENCE WITH STREPTOKINASE AS THROMBOLYTIC AGENT.
    AMERY A, VERMYLEN J, MAES H, VERSTRAETE M.
    Acta Haematol; 1964 Feb; 31():103-5. PubMed ID: 14131781
    [No Abstract] [Full Text] [Related]

  • 2. ANTICOAGULANTS PLUS STREPTOKINASE THERAPY IN PROGRESSIVE STROKE.
    MEYER JS, GILROY J, BARNHART MI, JOHNSON JF.
    JAMA; 1964 Aug 03; 189():373. PubMed ID: 14163124
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. EFFICACY OF THROMBOLYTIC THERAPY WITH STREPTOKINASE USING A NEW ADMINISTRATION SCHEME.
    VERSTRAETE M, VERMYLEN J, DEVREKER R, AMERY A, VERMYLEN C.
    Scand J Clin Lab Invest; 1964 Aug 03; 16():SUPPL 78:15-22. PubMed ID: 14199704
    [No Abstract] [Full Text] [Related]

  • 5. [CLINICAL EXPERIENCE WITH STREPTOKINASE AS A THROMBOLYTIC AGENT].
    VERSTRAETE M, AMERY A.
    Acta Cardiol; 1963 Aug 03; 18():235-47. PubMed ID: 14045888
    [No Abstract] [Full Text] [Related]

  • 6. THE PRESENT STATUS OF FIBRINOLYTIC THERAPY.
    CLIFFTON EE.
    Angiology; 1963 Nov 03; 14():533-41. PubMed ID: 14075024
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. FURTHER EXPERIENCE WITH STREPTOKINASE AS THROMBOLYTIC AGENT.
    AMERY A, VERMYLEN J, MAES H, VERSTRAETE V.
    Sangre (Barc); 1964 Nov 03; 61():9-11. PubMed ID: 14214896
    [No Abstract] [Full Text] [Related]

  • 9. FIBRINOLYTIC THERAPY OF THROMBOPHLEBITIS. TWENTY-FIVE CASES STUDIED WITH SERIAL VENOGRAMS.
    HECKER SP.
    Calif Med; 1964 Jul 03; 101(1):23-9. PubMed ID: 14179527
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [THROMBOLYTIC THERAPY. TRIAL TREATMENT WITH PURIFIED STREPTOKINASE].
    MARCHAL G, SOULIE P, BILSKI PASQUIER G, ABASTADO M, CASTEL A, GOGLIN G, PROST RJ, SAMAMA M.
    Arch Mal Coeur Vaiss; 1964 Jul 03; 57():753-72. PubMed ID: 14182459
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Current possibility of thrombolytic treatment].
    VERSTRAETE M, AMERY A.
    Brux Med; 1962 Dec 02; 42():1437-54. PubMed ID: 13996898
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [POSTOPERATIVE ARTERIAL EMBOLISM. TRIPLE TREATMENT (EMBOLECTOMY, ANTICOAGULANTS, THROMBOLYTIC AGENT). RECOVERY].
    MONOD-BROCA P.
    Mem Acad Chir (Paris); 1962 Dec 02; 90():563-7. PubMed ID: 14177153
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.